EzriCare and Delsam Pharma’s Artificial Eye Drop & Ointment bacterial outbreak

Q: Which eye products have been recalled?

Global Pharma has issued a voluntary recall of these three eye products: EzriCare Artificial Tears: NDC 79503-0101-15; UPC 3 79503 10115 7; Delsam Pharma’s Artificial Tears: NDC 72570-121-15; UPC -3 72570 12115 8; Delsam Pharma’s Artificial Eye Ointment: NDC: 72570-122-35; UPC: 3 72570 012235 3. These are all over-the-counter (OTC) products.

Q: Why are they being recalled?

The recalled eye drops may be contaminated by the drug-resistant strain of Pseudomonas aeruginosa bacteria. This can cause eye infections that may lead to blindness or even death from a bloodstream infection. The Centers for Disease Control (CDC) has identified several dozen patients suffering from infections that may be linked to EzriCare Artificial tears. One of them suffered permanent vision loss, and another died.

Q: What is the status of the litigation?

Lawsuits are in a very early stage. Based on growing evidence that Global Pharma grossly fell short of industry safety standards, attorneys anticipate bringing several strict liability-based claims, including defective design, manufacturing defect, and failure to warn/improper labeling. According to the Food and Drug Administration (FDA), Global Pharma has committed various current good manufacturing practice (CGMP) violations, such as: not doing microbial testing, not having controls re. its packaging, and not using adequate preservatives in its bottles. Furthermore, Global Pharma has not adequately responded to the FDA's record requests. The FDA has already put Global Pharma on an import alert, which precludes these recalled products from entering the U.S.

Q: Who makes the recalled eye drops and ointment?

Global Pharma Healthcare Private Limited makes the now-recalled EzriCare and Delsam Pharma eye drops and ointment. Both its factory and corporate office are located in Tamilnadu, India. It largely manufactures eye and skin products.

Shouse Law Group is suing Global Pharma for making contaminated eye drops and ointments that may cause bacterial infections, blindness, and even death.

Our attorneys represent victims throughout the United States who were injured by the now-recalled eye products:

EzriCare Artificial Tears
Delsam Pharma’s Artificial Tears
Delsam Pharma’s Artificial Eye Ointment

We are demanding from Global Pharma the highest settlement possible to compensate our clients for their medical bills, lost earnings, and pain and suffering.

In this article, our mass torts attorneys answer these frequently-asked-questions:

1. Which eye products have been recalled?

Global Pharma has issued a voluntary recall of these three eye products:

EzriCare Artificial Tears: NDC 79503-0101-15; UPC 3 79503 10115 7
Delsam Pharma’s Artificial Tears: NDC 72570-121-15; UPC -3 72570 12115 8
Delsam Pharma’s Artificial Eye Ointment: NDC: 72570-122-35; UPC: 3 72570 012235 3

These are all over-the-counter (“OTC”) products.¹

2. Why are they being recalled?

The recalled eye drops may be contaminated by the drug-resistant strain of Pseudomonas aeruginosa bacteria. This can cause eye infections that may lead to blindness or even death from a bloodstream infection.

The Centers for Disease Control (CDC) has identified several dozen patients suffering from infections that may be linked to EzriCare Artificial tears. One of them suffered permanent vision loss, and another died.²

Close-up of eye drop being dispense into woman's eye

EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, and Delsam Pharma’s Artificial Eye Ointment have been recalled.

3. What is the status of the litigation?

Lawsuits are in a very early stage. Based on growing evidence that Global Pharma grossly fell short of industry safety standards, attorneys anticipate bringing several strict liability-based claims, including

defective design
manufacturing defect
failure to warn/improper labeling

According to the Food and Drug Administration (FDA), Global Pharma has committed various current good manufacturing practice (CGMP) violations, such as:

not doing microbial testing
not having controls re. its packaging
not using adequate preservatives in its bottles

Furthermore, Global Pharma has not adequately responded to the FDA’s record requests. The FDA has already put Global Pharma on an “import alert“, which precludes these recalled products from entering the U.S.³

Ultimately, the thousands of anticipated lawsuits may be combined into a federal multi-district litigation (MDL) as a way to streamline the litigation and settlement process. (MDLs are not class-actions because your lawsuit remains separate.)

4. What money can I get?

If you have been injured by Global Pharma’s recalled eye drops or ointment, you may be able to get reimbursed for your:

medical expenses, including hospital bills
lost wages and loss of future earnings from being unable to work
pain and suffering (which is often the greatest expense)

The more severe your injury, the higher the potential settlement.

5. What should I do if I have been using these products?

The FDA advises that you immediately stop using EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears and Eye Ointment.

If you are suffering from unusual symptoms or have vision loss, contact your doctor. Then call our personal injury attorneys to discuss your legal options.

6. Who makes the recalled eye drops and ointment?

Global Pharma Healthcare Private Limited makes the now-recalled EzriCare and Delsam Pharma eye drops and ointment. Both its factory and corporate office are located in Tamilnadu, India. It largely manufactures eye and skin products.